Literature DB >> 30952370

Sentinel node mapping vs. lymphadenectomy in endometrial cancer: A systematic review and meta-analysis.

Giorgio Bogani1, Ferdinando Murgia2, Antonino Ditto1, Francesco Raspagliesi1.   

Abstract

Sentinel node mapping is increasingly being utilized for endometrial cancer staging. However, only limited evidence supporting the adoption of sentinel node mapping instead of conventional lymphadenectomy is still available. Here, we aimed to review the current evidence comparing sentinel node mapping and lymphadenectomy in endometrial cancer staging. This systematic review was registered in the International Prospective Register of Systematic Reviews. Six comparative studies were included. Overall, 3536 patients were included: 1249 (35.3%) and 2287 (64.7%), undergoing sentinel node mapping and lymphadenectomy, respectively. Pooled data suggested that positive pelvic nodes were detected in 184 out of 1249 (14.7%) patients having sentinel node mapping and 228 out of 2287 (9.9%) patients having lymphadenectomy (OR: 2.03; (95%CI: 1.30 to 3.18); p = 0.002). No difference in detection of positive nodes located in the paraaortic was observed (OR: 93 (95%CI: 0.39 to 2.18); p = 0.86). Overall recurrence rate was 4.3% and 7.3% after sentinel node mapping and lymphadenectomy, respectively (OR: 0.90 (95%CI: 0.58 to 1.38); p = 0.63). Similarly, nodal recurrences were statistically similar between groups (1.2% vs. 1.7%; OR: 1.51 (95%CI: 0.70 to 3.29); p = 0.29). In conclusion, our meta-analysis underlines that sentinel node mapping is non-inferior to standard lymphadenectomy in term of detection of paraaortic nodal involvement and recurrence rates (any site and nodal recurrence); while, focusing on the ability to detect positive pelvic nodes, sentinel node mapping could be consider superior to lymphadenectomy. Further randomized studies are needed to asses long term effectiveness of sentinel node mapping.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Detection rate; Endometrial cancer; Lymphadenectomy; Sentinel node mapping; Survival

Mesh:

Year:  2019        PMID: 30952370     DOI: 10.1016/j.ygyno.2019.03.254

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  18 in total

1.  Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Casper Reijnen; Joanna IntHout; Leon F A G Massuger; Fleur Strobbe; Heidi V N Küsters-Vandevelde; Ingfrid S Haldorsen; Marc P L M Snijders; Johanna M A Pijnenborg
Journal:  Oncologist       Date:  2019-06-11

2.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

3.  Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study.

Authors:  Shinichi Togami; Hiroaki Kobayashi; Hitoshi Niikura; Muneaki Shimada; Nobuyuki Susumu; Tomohito Tanaka; Yoshito Terai; Tomoyuki Nagai; Tsukasa Baba; Hideaki Yahata; Wataru Yamagami; Ken Yamaguchi; Tsuyoshi Yamashita; Nobuo Yaegashi; Hidetaka Katabuchi; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2021-03-25       Impact factor: 3.402

Review 4.  Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019.

Authors:  Lindsey M Charo; Steven C Plaxe
Journal:  F1000Res       Date:  2019-06-12

5.  Operative and Oncological Outcomes Comparing Sentinel Node Mapping and Systematic Lymphadenectomy in Endometrial Cancer Staging: Meta-Analysis With Trial Sequential Analysis.

Authors:  Yu Gu; Hongyan Cheng; Liju Zong; Yujia Kong; Yang Xiang
Journal:  Front Oncol       Date:  2021-01-13       Impact factor: 6.244

6.  The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer.

Authors:  Zhao Liu; Jinghe Lang; Ming Wu; Lei Li
Journal:  Front Oncol       Date:  2021-02-16       Impact factor: 6.244

7.  Sentinel lymph node detection in endometrial cancer with indocyanine green: laparoscopic versus robotic approach.

Authors:  N Bizzarri; S Restaino; S Gueli Alletti; G Monterossi; A Gioè; E La Fera; V Gallotta; A Fagotti; G Scambia; F Fanfani
Journal:  Facts Views Vis Obgyn       Date:  2021-03-31

8.  Status of Sentinel Lymph Node Biopsy in Endometrial Cancer.

Authors:  Florin Andrei Taran; Lisa Jung; Julia Waldschmidt; Sarah Isabelle Huwer; Ingolf Juhasz-Böss
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-05-20       Impact factor: 2.915

Review 9.  Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review.

Authors:  Lirong Zhai; Xiwen Zhang; Manhua Cui; Jianliu Wang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

Review 10.  Uterine serous carcinoma.

Authors:  Giorgio Bogani; Isabelle Ray-Coquard; Nicole Concin; Natalie Y L Ngoi; Philippe Morice; Takayuki Enomoto; Kazuhiro Takehara; Hannelore Denys; Remi A Nout; Domenica Lorusso; Michelle M Vaughan; Marta Bini; Masashi Takano; Diane Provencher; Alice Indini; Satoru Sagae; Pauline Wimberger; Robert Póka; Yakir Segev; Se Ik Kim; Francisco J Candido Dos Reis; Salvatore Lopez; Andrea Mariani; Mario M Leitao; Francesco Raspagliesi; Pieluigi Benedetti Panici; Violante Di Donato; Ludovico Muzii; Nicoletta Colombo; Giovanni Scambia; Sandro Pignata; Bradley J Monk
Journal:  Gynecol Oncol       Date:  2021-04-30       Impact factor: 5.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.